Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

1.03
Delayed Data
As of 3:59pm ET
 -0.02 / -1.90%
Today’s Change
0.73
Today|||52-Week Range
1.78
-18.25%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close1.05
Today’s open1.05
Day’s range1.02 - 1.05
Volume1,723,602
Average volume (3 months)5,948,334
Market cap$308.9M
Dividend yield--
Data as of 3:59pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)-71.67%
Earnings growth (this year)+39.92%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-57.65%
P/E ratioNM
Price/Sales22.22
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc-0.07-1.62%
EDGEEdge Therapeutics In...+0.31+2.96%
BTXBioTime Inc-0.05-1.89%
RIGLRigel Pharmaceutical...-0.13-3.34%
Data as of 4:09pm ET, 10/23/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$15.4M
Annual profit (last year)-$280.0M
Net profit margin-1,823.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Senior VP-
Global Manufacturing Operations
Timothy Jon Hahn
Corporate headquarters
Gaithersburg, Maryland

Forecasts